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Behavioral/Systems/Cognitive

SIRT1 Promotes the Central Adaptive Response to Diet
Restriction through Activation of the Dorsomedial and
Lateral Nuclei of the Hypothalamus
Akiko Satoh,1 Cynthia S. Brace,1 Gal Ben-Josef,5 Tim West,2 David F. Wozniak,3,4 David M. Holtzman,1,2,4
Erik D. Herzog,4,5 and Shin-ichiro Imai1
Departments of 1Developmental Biology, 2Neurology, and 3Psychiatry and 4Hope Center for Neurological Disorders, Washington University School of
Medicine, St. Louis, Missouri 63110, and 5Department of Biology, Washington University, St. Louis, Missouri 63130

Diet restriction retards aging and extends lifespan by triggering adaptive mechanisms that alter behavioral, physiological, and biochemical responses in mammals. Little is known about the molecular pathways evoking the corresponding central response. One factor that
mediates the effects of diet restriction is the mammalian nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1. Here
we demonstrate that diet restriction significantly increases SIRT1 protein levels and induces neural activation in the dorsomedial and
lateral hypothalamic nuclei. Increasing SIRT1 in the brain of transgenic (BRASTO) mice enhances neural activity specifically in these
hypothalamic nuclei, maintains a higher range of body temperature, and promotes physical activity in response to different dietrestricting paradigms. These responses are all abrogated in Sirt1-deficient mice. SIRT1 upregulates expression of the orexin type 2
receptor specifically in these hypothalamic nuclei in response to diet-restricting conditions, augmenting response to ghrelin, a gut
hormone whose levels increase in these conditions. Our results suggest that in the hypothalamus, SIRT1 functions as a key mediator of the
central response to low nutritional availability, providing insight into the role of the hypothalamus in the regulation of metabolism and
aging in mammals.

Introduction
Animals employ a variety of strategies to survive when food is
limited, including adaptive mechanisms that alter their behavioral, physiological, and biochemical responses to low nutritional
inputs. For example, it has been reported that animals reduce
their physical activity during the initial stages of food deprivation, but increase it during the later stages (Wang et al., 2006).
This increase in physical activity could be an adaptive response to
search for food and to survive through such life-threatening conditions. In rodents, the increase in physical activity has also been
observed in diet restriction (DR) (Yu et al., 1985; Ingram et al.,
1987), the single, most reliable regimen known to retard aging
and extend lifespan in a variety of organisms, including yeast (Lin
et al., 2000), worms (Lakowski and Hekimi, 1998), flies (Chapman
and Partridge, 1996), rodents (McCay et al., 1935; Weindruch and
Walford, 1982), and primates (Colman et al., 2009). DR has also

Received March 17, 2010; revised June 10, 2010; accepted June 17, 2010.
This work was supported by the National Institute on Aging (AG02150), the Ellison Medical Foundation, and the
Longer Life Foundation to S.I. A.S. is supported by Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad. S.I. serves as a scientific advisory board member for Sirtris, a GSK company. We thank
Daniel Granados-Fuentes, Tatsiana Simon, and Sara Conyers for help with mouse behavioral tests, Christian Beaule
for help with cFOS staining, Elise Oster for cloning of the mouse Ox2r promoter, and members of the Imai laboratory
for their help and discussions.
Correspondence should be addressed to Dr. Shin-ichiro Imai, Department of Developmental Biology, Washington
University School of Medicine, Campus Box 8103, 660 South Euclid Avenue, St. Louis, MO 63110. E-mail:
imaishin@wustl.edu.
DOI:10.1523/JNEUROSCI.1385-10.2010
Copyright © 2010 the authors 0270-6474/10/3010220-13$15.00/0

been known to delay the onset and slow the progression of many
age-related diseases (Weindruch et al., 1986; Bronson and Lipman,
1991; Fontana et al., 2004; Colman et al., 2009). Whereas a number of hypotheses have been proposed to explain mechanisms for
the physiological effects of DR (Masoro, 2005), recent evidence
suggests that DR triggers highly coordinated adaptive responses
that translate nutritional cues to alterations in fundamental cellular processes, thereby mediating a variety of physiological responses at a systemic level (Sinclair, 2005; Bishop and Guarente,
2007a).
Although little is known about the mechanisms of these adaptive responses to DR, the evolutionarily conserved Sir2 (silent
information regulator 2) family of NAD-dependent deacetylases/
ADP-ribosyltransferases, also called “sirtuins,” has recently
drawn much attention as a critical regulator that mediates physiological responses to DR (Sinclair, 2005; Bishop and Guarente,
2007a; Imai, 2009a). Sirtuins play a critical role in the regulation
of aging and longevity in experimental model organisms, such as
yeast, worms, and flies (Kaeberlein et al., 1999; Tissenbaum and
Guarente, 2001; Rogina and Helfand, 2004). Sirtuins are also
required for the DR-mediated lifespan extension in those organisms with certain genetic backgrounds (Lin et al., 2000; Anderson
et al., 2003; Rogina and Helfand, 2004; Wang and Tissenbaum,
2006). In mammals, there are seven sirtuins, SIRT1 through
SIRT7. Numerous studies have demonstrated that SIRT1 regulates essential metabolic pathways in response to low energy intake in multiple tissues, as well as cell survival in response to stress
and damage (Sinclair, 2005; Imai and Guarente, 2007; Schwer
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and Verdin, 2008). Results from loss- and gain-of-function
mouse studies have provided genetic evidence connecting SIRT1
to DR (Imai, 2009a). For example, it has been reported that the
DR-induced elevation of physical activity is abrogated in Sirt1deficient mice (Chen et al., 2005), providing a clue for the potential role of SIRT1 in the central regulation of physiological
response to DR. Therefore, we decided to examine whether and
how SIRT1 controls central adaptive responses to DR using both
gain- and loss-of-function SIRT1 mutant mice. Our present
study reveals a novel function for SIRT1 in the hypothalamus,
particularly in the dorsomedial and lateral hypothalamic nuclei,
as a key mediator of the central adaptive response to DR. These
findings also provide important insight into the physiological
mechanism that conveys the anti-aging and the lifespanextending effects of DR in mammals.

Materials and Methods
BRASTO and Sirt1-deficient mice. To generate brain-specific SIRT1overexpressing (BRASTO) transgenic mice, the mouse prion (PrP)
promoter-driven, HA-tagged Sirt1 transgene was constructed by inserting a 2.3 kb fragment of the mouse Sirt1 cDNA into the vector carrying
the mouse PrP promoter (Wang et al., 2005) (a kind gift from Dr. David
Borchelt, University of Florida, Gainesville, FL) after eliminating three
NotI sites without changing the SIRT1 amino acid sequence and adding
the HA tag to the 3⬘ end of the Sirt1 coding sequence. The PrP-Sirt1-HA
transgene was linearized, purified, and microinjected into C57BL/6J ⫻
CBA hybrid blastocysts in the Washington University Mouse Genetic
Core Facility. Transgenic mice were identified by PCR genotyping with
tail DNA. Two transgenic founders (lines 1 and 10) were established, and
the mice were backcrossed to wild-type C57BL/6 mice (Jackson Laboratories) for 6 –7 generations before analysis. Nontransgenic littermates
were used as controls. Sirt1-deficient (Sirt1 ⫺/ ⫺) mice, which were originally established in the 129sv/B6 mixed background, were described
previously (Cheng et al., 2003). Sirt1-heterozygous mice were backcrossed to wild-type FVB mice (Jackson Laboratories) for six generations
(a kind gift from Dr. Jeffrey Milbrandt, Washington University, St. Louis,
MO), and Sirt1 ⫺/ ⫺ mice were generated by crossing Sirt1-heterozygous
mice. Sirt1 ⫺/ ⫺ FVB mice at 3–5 months of age were used for this study.
Diet-restricting paradigms. For 48 h fasting, chow was removed from
both male and female mice at 4 –5 months of age at 8:30 A.M. for 48 h.
After 48 h fasting, the ambulatory behavior of mice was carefully recorded by a video camera, and physical activity was scored by counting
the number of times that each mouse crossed from one quadrant to
another over 10 min (supplemental Movies S1– 4, available at www.
jneurosci.org as supplemental material). For DR, wild-type C57BL/6,
BRASTO, Sirt1 ⫺/ ⫺, and respective control male mice at 8 –12 weeks of
age were fed with 1 g pellets of a semisynthetic chow, AIN-93M (Bioserv).
Ad libitum-fed (AL) control mice were given pellets equal to calculated
average daily food intake (⬃4 pellets), while diet-restricted mice were
given pellets equal to 60% of average daily food intake. For short-term
DR (14 d), mice were fed everyday at 5:00 P.M. and killed between 9:00
A.M. and 10:00 A.M. To assess the effects of this short-term DR on
locomotor activity, the groups were tested over a 24 h (12 h/12 h light/
dark) period according to previously published procedures (Wozniak et
al., 2004). For long-term DR (104 d), the feeding cycle was as follows: 8
and 4 –5 pellets on Monday and Wednesday and 10 –11 and 6 –7 pellets
on Friday for AL and DR mice, respectively, and chow was delivered
between 4:00 and 5:00 P.M. This DR regimen with intermittent feeding is
to create conditions that allow us to conduct other physiological tests,
such as intraperitoneal glucose tolerance tests, as similar as possible to
regular procedures. In one of these DR experiments, for example, after 3
months of DR, glucose levels on Thursday morning were 150 ⫾ 6.9 and
105 ⫾ 4.5 mg/dl for AL and DR males, respectively, while glucose levels
on Friday morning were 130 ⫾ 6.0 and 76.4 ⫾ 6.1 mg/dl for AL and DR
males, respectively. Therefore, physiological tests that normally require
fasting before the experiments were usually conducted on Wednesday or
Friday morning, and we confirmed that DR mice showed significantly
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improved glucose tolerance (data not shown). However, to separate the
long-term effects of DR from those of fasting, tissue and plasma samples
were collected between 9:00 A.M. and 10:00 A.M. on Tuesday and Thursday morning. For timed DR, male mice at 4 –5 months of age were
maintained in 12 h/12 h light/dark schedule and housed individually
with a running wheel. Mice were fed only from 1:00 P.M. [zeitgeber time
6 (ZT6)] to 5:00 P.M. (ZT10). Running-wheel revolutions in 1 min bins
were recorded using Clocklab software (Actimetrics) as described previously (Aton et al., 2004). All animal procedures were approved by the
Washington University Animal Studies Committee.
Twenty-four-hour locomotor activity test. Starting at 10:00 –10:30 A.M.,
locomotor activity was evaluated over a 24 h period by placing individual
mice into transparent (47.6 ⫻ 25.4 ⫻ 20.6 cm high) polystyrene enclosures as described in previous studies involving a 1 h test (Wozniak et al.,
2004). Each enclosure was surrounded by a frame containing a 4 ⫻ 8
matrix of photocell pairs, the output of which was fed to an on-line
computer (Hamilton-Kinder). Another frame that contained eight pairs
of photocells and was raised 7 cm above the floor of the enclosure was
used to quantify vertical activity. Variables that were analyzed included
the total number of ambulations (whole-body movements), as well as the
number of vertical rearings over the 24 h period.
Rectal body temperature. Rectal body temperature was measured at
9:00 –9:30 A.M. by a Microtherma 2 Type (TW2-193) thermometer with
a mouse rectal probe (model RET-3).
Immunohistochemistry. Mice were anesthetized with ketamine/xylazine and perfused with PBS followed by 4% paraformaldehyde (PFA).
Brains were fixed with 4% PFA overnight and placed into 15% sucrose
followed by 30% sucrose. Thirty-micrometer sections were made by a
cryostat and stored at ⫺30°C. Immunostaining results were analyzed for
each hypothalamic nucleus as follows: Because brain sections from one
mouse were used for multiple analyses, hypothalamic sections at the
same coronal planes were always chosen for all mice analyzed. For each
mouse, two brain sections around bregma ⫺0.82 mm were used for the
PVN and SCN and one to two brain sections around bregma ⫺1.58 mm
were used to cover the Arc, VMH, DMH, and LH. We usually used three
to four mice for each analysis and therefore analyzed four to eight sections per hypothalamic nucleus. When signals/counts were relatively
low, we analyzed more sections. To quantify SIRT1 protein signals in
each hypothalamic nucleus, brain sections were stained by 3,3⬘diaminobenzidine (DAB) with rabbit anti-mouse SIRT1 (1:3000)
(Moynihan et al., 2005) and biotinylated goat anti-rabbit IgG (1:500)
antibodies with the ABC kit (Vector Laboratories). SIRT1 protein signals
were quantified by measuring the intensity per area in each hypothalamic
nucleus after subtracting surrounding background signal levels using the
Histogram function of Adobe Photoshop. For double immunofluorescent staining of HA-tagged SIRT1, samples were stained first with the
same rabbit anti-mouse SIRT1 (1:1000) and HRP-conjugated goat antirabbit IgG (1:2000) antibodies using the FITC TSA kit (Parkin Elmer)
and then with anti-HA (1:1000, Covance) and HRP-conjugated goat
anti-mouse IgG (1:10,000) antibodies using the Cy3 TSA kit, according
to the manufacturer’s protocol. To stain cFOS in each hypothalamic
nucleus, samples were stained by the DAB detection method with anticFOS (1:100,000, Calbiochem) and biotinylated goat anti-rabbit IgG (1:
200) antibodies with the ABC kit. The numbers of cFOS-positive cells
were quantified by ImageJ software. For the double staining of cFOS and
OX2R, samples were stained for cFOS first and then with anti-OX2R
(1:100, Alpha Diagnostics) and HRP-conjugated goat anti-rabbit IgG
(1:1000) antibodies with the Cy3 TSA kit.
In situ hybridization. Brain sections were fixed in 4% PFA, acetylated
with triethanol amine/acetic anhydrite, and prehybridized in hybridization buffer (10 mM Tris-HCl [pH 7.4], 600 mM NaCl, 1 mM EDTA, 1⫻
Denhardt’s solution, 25 g/ml yeast ribosomal RNA, 12.5 g/ml salmon
testis DNA, 10% dextran sulfate, and 40% formamide). Prehybridized
samples were then hybridized in hybridization buffer containing digoxigenin (DIG)-labeled antisense RNA probes of Ox2r (nucleotides 5951034) at 60°C overnight. Sense probes were used as negative controls.
After samples were hybridized, samples were sequentially washed with
2⫻ SSC/50% formamide, 0.1⫻ SSC, and washing buffer (100 mM maleic
acid, 150 mM NaCl, 0.3% Tween 20, pH 7.5) and then incubated with
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blocking solution (PerkinElmer). Signals were visualized by incubating
with a peroxidase-conjugated anti-DIG antibody and the TSA kit. The
signal intensity per area in each hypothalamic nucleus was quantified
after subtracting surrounding background signal levels by using the Histogram function of Adobe Photoshop.
Laser-microdissection. The brain was removed, immediately frozen in
OCT compound on dry ice, and stored at ⫺80°C until laser-microdissection. Twenty-five-micrometer brain sections were mounted on PENmembrane slides (Leica), and kept on dry ice. The mounted slides were
hydrated sequentially in 100%, 95%, 75%, and 50% ethanol for 30 s each.
The hydrated slides were stained with 1% Cresyl Violet (Sigma) for 1
min, and dehydrated with 50%, 75%, 95%, and 2 cycles of 100% ethanol
for 30 s each. The dehydrated slides were then incubated in xylene twice
for 1 min each. After being air-dried for 5 min, Arc, VMH, DMH, and LH
were microdissected using the Leica LMD 6000 laser-microdissection
system.
Quantitative real-time RT-PCR. Total RNA was extracted from each
hypothalamic nucleus using the RNeasy kit (Qiagen) and reversetranscribed into cDNA with the High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Quantitative real-time RT-PCR was
conducted with the TaqMan Fast Universal PCR Master mix and appropriate TaqMan primers for each gene in the GeneAmp 7500 fast sequence
detection system (Applied Biosystems). Relative expression levels were
calculated for each gene by normalizing to Gapdh levels and then to one
of the wild-type control individuals.
Luciferase assay. HEK293 cells were transfected with a luciferase reporter driven by a ⬃1 kb Ox2r promoter and a Sirt1 minigene or a control
vector (Revollo et al., 2004). Transfected cells were cultured in media
with 5 mM glucose for 48 h. Cell extracts were prepared, and luciferase
activity was determined with the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s protocol. Luciferase activity
levels were normalized to protein concentrations of each sample.
Chromatin-immunoprecipitation assay. Mouse hypothalamus was incubated sequentially with freshly prepared 5 mM DTBP and 1% PFA.
After washing with PBS, pellets were stored at ⫺80°C until analysis.
Pellets were resuspended in buffer (1% Triton X-100, 0.1% deoxycholate, 50 mM Tris-HCl [pH 8.1], 5 mM EDTA, 150 mM NaCl, 1% SDS,
and protease inhibitors) and placed on ice for 20 min. After centrifugation, chromatin was sheared by sonicating with nuclei buffer (50 mM
Tris-HCl, pH 8.0, 10 mM EDTA, 0.01% SDS, and 0.1 mM PMSF) to a final
size between 200 bp and 600 bp. Before immunoprecipitation, soluble
chromatin was incubated with protein A agarose/salmon slurry (Millipore) at 4°C for 30 min. An aliquot of supernatant was removed as
“input” and used in PCR analysis. The remainder of supernatant was
incubated with SIRT1 antibody or rabbit IgG at 4°C overnight. Immune
complexes were isolated by incubating with protein A agarose/salmon
slurry for 1.5 h at 4°C. The complexes were washed with low-salt buffer,
high-salt buffer, LiCl buffer, and TE, pH 8.0. The complexes were eluted,
de-cross-linked with 125 mM NaCl at 65°C overnight, and then treated
with RNase A at 37°C for 30 min and with proteinase K at 45°C for 90
min. The purified DNA was resuspended with TE and analyzed by PCR
by specific primer sets.
Measurement of serum ghrelin levels. Mouse plasma samples were collected into tubes containing 4-(2-aminoethyl)-benzenesulfonyl fluoride
(AEBSF, Sigma), incubated for 30 min at room temperature, and centrifuged at 5000 ⫻ g for 10 min at 4°C. The supernatant was stored at ⫺30°C
until analysis. The levels of ghrelin in serum were determined by a rat/
mouse total ghrelin ELISA kit (LINCO Research).
Ghrelin administration. After 4 d of habituation to handling and mock
injection, BRASTO, Sirt1 ⫺/ ⫺, and control male mice were injected with
octanoylated rat ghrelin (Pi Proteomics) at a dose of 30 nmol/kg body
weight or with an equal volume of PBS. Ninety and one hundred twenty
minutes after injection, mice were anesthetized and killed to collect
brains.
Statistical analyses. Statistical analyses were performed using unpaired
or paired Student’s t tests for two groups and one-way ANOVA with the
Tukey–Kramer post hoc test for more than two groups. Two-way
ANOVA was also applied to the data shown in Figures 2 A, 3D, 3E, 4 A,
4 D, 4 E, 7A, and 7C, to assess the main effects of two different factors and

the interaction between them. For this analysis, full statistics are presented in supplemental Table S1 (available at www.jneurosci.org as supplemental material). A Wilcoxon matched-pairs signed-ranks test was
used to compare differences of hourly wheel counts through the light and
dark times between wild-type versus BRASTO mice and day 0 vs day 5 in
each genotype, respectively. In all analyses, we set the ␣ level at 0.05. We
used Microsoft Excel 2008 and SPSS 11.0 to conduct statistical analyses.

Results
SIRT1 is expressed in major hypothalamic nuclei
We initially surveyed the expression pattern of the SIRT1 protein
in the mouse brain using a rabbit polyclonal, affinity-purified
antibody (Imai et al., 2000). This antibody did not produce any
significant positive signals on Sirt1-deficient brain sections, assuring its specificity (supplemental Fig. S1 A, B, available at www.
jneurosci.org as supplemental material). SIRT1 showed nuclear
localization in the hypothalamus and hippocampus, and extranuclear localization in dorsal regions of the cerebral cortex
(data not shown). In the hypothalamus, SIRT1 was expressed in
the arcuate nucleus (Arc), the ventromedial, dorsomedial, and
lateral hypothalamic nuclei (VMH, DMH, and LH, respectively),
and the paraventricular nucleus (PVN), brain regions that all play
critical roles in the central regulation of adaptive responses to
food availability (Elmquist, 2001) (Fig. 1 A). SIRT1 was also expressed in the suprachiasmatic nucleus (SCN), a region important for the central regulation of circadian rhythm (Green et al.,
2008) (Fig. 1 A). These results are consistent with the reported
distribution of Sirt1 mRNA in the hypothalamus (Ramadori et
al., 2008).
Both SIRT1 levels and the number of activated neurons
increase in the DMH and LH of diet-restricted hypothalami
Because SIRT1 protein levels are upregulated and downregulated
in multiple tissues and even within the same tissue in response to
DR (Imai and Guarente, 2007; Chen et al., 2008; Schwer and
Verdin, 2008), we decided to examine whether SIRT1 protein
levels were also altered in hypothalamic nuclei of diet-restricted
mice. Using a semiquantitative DAB-based immunostaining
method with our highly specific SIRT1 antibody (supplemental
Fig. S1 A, B, available at www.jneurosci.org as supplemental material), we found that SIRT1 protein levels moderately but specifically increased in the DMH, LH, and SCN, but not in the Arc,
VMH, or PVN, in response to short-term (14 d) DR (DMH, p ⫽
0.047; LH, p ⫽ 0.043; SCN, p ⫽ 0.007) (Fig. 1 B; supplemental Fig.
S2, available at www.jneurosci.org as supplemental material). We
also observed significant increases in the number of cFOSpositive cells, a well established marker of neural activation
(Sagar et al., 1988; Dragunow and Faull, 1989), in the DMH and
LH under DR (DMH, p ⫽ 0.019; LH, p ⬍ 0.001) (Fig. 1C,D).
Neither the hippocampus nor the cortex showed any significant
increase in cFOS-positive cells (data not shown). Similar results
were obtained in hypothalami under long-term (104 d) DR (supplemental Fig. S3A–D, available at www.jneurosci.org as supplemental material). These findings suggest that a moderate but
continuous increase in SIRT1 dosage and/or activity might play
an important role in neural activation in the DMH and LH in
response to DR.
To address this possibility, we generated transgenic mice in
which SIRT1 protein levels are selectively increased in the brain
(BRASTO). BRASTO transgenic mice express a C-terminally
HA-tagged mouse SIRT1 cDNA driven by the mouse prion promoter (Fig. 1 E). We established two independent BRASTO
transgenic lines, lines 1 and 10. Both lines showed moderate in-
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Figure 1. SIRT1 is expressed in major hypothalamic nuclei, and both SIRT1 levels and the number of activated neurons increase in the DMH and LH in diet-restricted hypothalami. A, Immunofluorescent staining of SIRT1 (green) in major hypothalamic nuclei, including the PVN, SCN, Arc, VMH, DMH, and LH. Nuclei are counterstained by DAPI (gray). B, Signal intensities of SIRT1 staining
in hypothalami after 14 d DR compared to AL (*p ⬍ 0.05, **p ⬍ 0.01, n ⫽ 4 mice, 4 – 8 sections per hypothalamic nucleus). The signal intensity per area was digitally quantified after subtracting
surrounding background. Results are shown as mean values ⫾ SEM. C, D, cFOS staining in the DMH and LH after 14 d DR (C), and quantification of the number of cFOS-positive cells in hypothalamic
nuclei (*p ⬍ 0.05, ***p ⬍ 0.001, n ⫽ 4 mice, 4 – 8 sections per hypothalamic nucleus). The numbers of cFOS-positive cells are shown as mean values ⫾ SEM (D). E, Transgene structure for the
production of BRASTO mice (upper panel) and distribution of SIRT1 in major brain regions in both lines 1 and 10 of BRASTO mice (lower panels). F, Immunofluorescent staining of SIRT1 (green) and
HA (red) in hypothalami of BRASTO line 10. Nuclei are counterstained by DAPI (gray).

creases in SIRT1 protein expression in the brain (2.5- to 5.1- and
1.5- to 2.5-fold increases in lines 1 and 10, respectively) (Fig. 1 E).
There were ⬃2-fold increases in SIRT1 levels in the kidney in
both lines and heart in line 1 (supplemental Fig. S4 A, available at
www.jneurosci.org as supplemental material). Interestingly, expression profiles of the overexpressed SIRT1 protein mimicked

that of endogenous SIRT1 (Fig. 1 F; supplemental Fig. S4 B, available at www.jneurosci.org as supplemental material). Particularly
in line 10, SIRT1 was overexpressed 2.7-fold in the DMH and
1.8-fold in the LH (supplemental Fig. S1 B, right panel, available
at www.jneurosci.org as supplemental material), a similar profile
of increases in SIRT1 levels detected in the hypothalami of diet-
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restricted wild-type mice (Fig. 1 B). These
BRASTO mice were born normally and
did not show any gross abnormalities. We
examined their fed and fasted plasma glucose and insulin levels, body weight, food
intake, and glucose and insulin tolerance
at the age of 5 months but did not detect
any significant differences between
BRASTO and control mice (supplemental
Fig. S5, available at www.jneurosci.org as
supplemental material).
BRASTO mice exhibit enhanced
physical activity in response to diverse
diet-restricting paradigms
During the course of our metabolic assessments, we noticed that BRASTO female
mice were more active compared to control mice after 48 h fasting (supplemental
Movies S1– 4, available at www.jneurosci.
org as supplemental material). When
quantitated, BRASTO females in both
lines 1 and 10 showed enhanced physical
activity compared to control mice after
48 h fasting (WT vs Tg, line 1, p ⫽ 0.008;
line 10, p ⫽ 0.076; percentage count, L1,
p ⫽ 0.002; L10, p ⫽ 0.060) (Fig. 2 A; supplemental Table S1, available at www.
jneurosci.org as supplemental material).
This phenotype was not obvious in
BRASTO males, although there appears to Figure 2. BRASTO mice exhibit enhanced physical activity in response to multiple diet-restricting paradigms. A, Physical activity
be a similar trend, particularly in line 10 levels of BRASTO female mice after 48 h fasting in line 1 (left) and line 10 (middle). Activity counts (the numbers of quadrants
(supplemental Fig. S6 A, available at www. crossed; left and middle) and percentage counts relative to the fed condition (right) are shown as mean values ⫾ SEM (**p ⬍ 0.01,
jneurosci.org as supplemental material). ***p ⬍ 0.001 by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 9 –12 mice). B, Numbers of total ambulations (left) and
Therefore, instead of an acute fasting con- rearings (right) of BRASTO (Tg) and control (WT) male mice in line 10 after 14 d DR are shown as mean values ⫾ SEM (*p ⬍ 0.05,
dition, we evaluated the general locomo- **p ⬍ 0.01, n ⫽ 6 mice). L/D, Light plus dark periods; D, dark period alone. C, Wheel-running activity levels of BRASTO male mice
tor activity in BRASTO and control males in line 10 during a timed DR paradigm. Activity counts per hour through a 24 h light/dark cycle are shown. Shading represents
feeding time (ZT6 to 10). Counts at each time point are shown as mean values ⫾ SEM (day 0 vs day 5, *p ⬍ 0.05, **p ⬍ 0.01,
following a more chronic (14 d) DR con***p ⬍ 0.001 by paired Student’s t or Wilcoxon matched-pairs signed-ranks tests; WT vs Tg, §p ⬍ 0.05 by a Wilcoxon matcheddition. Interestingly, while diet-restricted pairs signed-ranks test; n ⫽ 5–10 mice).
BRASTO males showed a trend toward
more total ambulations (whole-body
ticularly ZT5– 6 right before feeding time, and a greater decrease
movements) over a 24 h light/dark cycle, they exhibited signifiin their night-time activity at ZT12–18 ( p ⫽ 0.047) (Fig. 2C),
cantly higher counts of rearing (vertical activity) compared to
supporting the idea that BRASTO mice might be able to reallocontrols (light plus dark periods, p ⫽ 0.049; dark period alone,
cate their physical activity more efficiently than control mice,
p ⫽ 0.007) (Fig. 2 B). This increase in rearing activity was more
with the plausible purpose of seeking food. Together, these findobvious particularly during the dark period. Increases in rearing
ings suggest that SIRT1 in the brain plays an important role in
often signify heightened arousal levels and augmented environpromoting physical activity in response to different dietmental exploration and nonselective attention (Vallone et al.,
restricting conditions.
2002). Therefore, these findings suggest that both BRASTO males
and females have a greater propensity to increase their physical
BRASTO mice show enhanced neural activation in the DMH
activity compared to control mice in response to diet-restricting
and LH in response to diet-restricting conditions
conditions.
We next examined which brain regions were more highly actiWe also examined BRASTO and control mice in a different
vated in BRASTO mice than in controls in response to different
experimental paradigm in which they were fed daily from 1:00
diet-restricting paradigms. In ad libitum conditions, there were
P.M. (ZT6) to 5:00 P.M. (ZT10). In this timed DR paradigm, the
only very small numbers of cFOS-positive cells in both wild-type
food-anticipating activity (FAA) of mice significantly increases
and BRASTO hypothalami, except for the SCN that normally
within several days of timed DR (Mistlberger, 1994; Stephan,
shows circadian rhythms of neural activation (Gooley et al.,
2002). Under this paradigm, BRASTO mice in both lines 1 and 10
2006), and no significant differences were observed between
exhibited enhanced FAA compared to control mice after 5 d of
wild-type and BRASTO mice (supplemental Fig. S7A, available at
timed DR, although line 1 showed a much larger variability (supwww.jneurosci.org as supplemental material). After 48 h fasting,
plemental Fig. S6 B, available at www.jneurosci.org as supple90%, 46%, and 163% increases in the numbers of cFOS-positive
mental material). Interestingly, BRASTO mice showed a greater
increase in their FAA during ZT0 – 6 ( p ⫽ 0.03) (Fig. 2C), parcells were detected in the DMH, LH, and PVN of BRASTO mice,
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other hypothalamic nuclei did not show
any significant differences between
BRASTO and control mice, further supporting the importance of the DMH and
LH in response to diet-restricting conditions. Because chow was always delivered
between 4:00 P.M. and 5:00 P.M. in this
DR regimen (see Materials and Methods),
the observed activation of the DMH and
LH does not appear to be related to the
time of feeding. In the timed DR paradigm, 67% and 120% increases in the
numbers of cFOS-positive cells were detected on day 5, first in the DMH and then
in the LH of BRASTO mice, respectively,
compared to those in control mice during
the 2 h time course before feeding (DMH,
p ⫽ 0.034; LH, p ⫽ 0.002) (Fig. 3C; supplemental Fig. S7D, available at www.
jneurosci.org as supplemental material).
The SCN is known to show circadian
rhythms of neural activation peaking
around ZT6 (Gooley et al., 2006). SIRT1
appears to suppress this oscillatory pattern,
qualitatively consistent with the effect of
SIRT1 on peripheral circadian rhythms
(Nakahata et al., 2008; Ramsey et al., 2009).
Thus, the most important point concerning
these results is that the enhanced neural activation in the DMH and LH is tightly associated with increased physical activity in
BRASTO mice under all three dietrestricting paradigms that we examined,
namely, 48 h fasting, DR, and timed DR.
To further confirm that the observed
enhancement of DMH and LH activation
Figure 3. BRASTO mice show enhanced neural activation in the DMH and LH in response to multiple diet-restricting paradigms. in BRASTO hypothalami is physiologiA–C, Quantification of cFOS-positive cells in major hypothalamic nuclei after 48 h fasting (A), 14 d DR (B), and 5 d of timed DR (C) cally relevant, we examined rectal body
in BRASTO mice in line 10 (*p ⬍ 0.05, **p ⬍ 0.01, n ⫽ 4 for 48 h fasting and DR, 4 – 8 sections per hypothalamic nucleus; n ⫽ 2 temperature in BRASTO and control
at each time point for timed DR, 2–5 sections per hypothalamic nucleus). The numbers of cFOS-positive cells are shown as mean mice in response to 48 h fasting and DR. It
values ⫾ SEM. D, E, Rectal body temperature of BRASTO mice after 48 h fasting (D) and during 14 d DR (E). Levels of rectal body has been demonstrated that neural actitemperature are shown as mean values ⫾ SEM (*p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001 by one-way ANOVA with Tukey–Kramer
vation in the DMH and LH plays an
post hoc test, n ⫽ 6 –7 for 48 h fasting, n ⫽ 6 for DR).
important role in the induction of thermogenesis in rodents (Cerri and Morrison,
respectively, compared to those of control mice (DMH, p ⫽
2005; DiMicco and Zaretsky, 2007; Morrison et al., 2008). While
0.0014; LH, p ⫽ 0.048; PVN, p ⫽ 0.002) (Fig. 3A; supplemental
both BRASTO and control mice showed significant decreases in
Fig. S7B, available at www.jneurosci.org as supplemental materectal body temperature after 48 h fasting and 14 d DR, BRASTO
rial). The profile of the increases in cFOS-positive cells in hypomice were able to maintain higher levels of rectal body temperathalamic nuclei of fasted BRASTO mice were very similar to those
ture compared to controls (WT vs Tg, fasted, p ⫽ 0.032; DR, p ⫽
in diet-restricted wild-type mice (Fig. 1 D), with the exception of
0.023) (Fig. 3 D, E; supplemental Table S1, available at www.
the additional neural activation in the PVN. As the PVN is known
jneurosci.org as supplemental material), consistent with ento control the stress response through the stimulation of gluhanced physical activity (Fig. 2 A, B) and enhanced neural
cocorticoid secretion from adrenal glands, this additional PVN
activation in the DMH and LH (Fig. 3 A, B) in fasted and dietactivation might correspond to a stress component imposed by
restricted BRASTO mice. These results further support the imsustained food anticipation under 48 h fasting. Indeed, a small
portance of SIRT1 in the regulation of neural activation in the
but significant increase in plasma corticosterone levels was deDMH and LH in response to different diet-restricting paradigms.
tected in fasted BRASTO females, compared to those in control
fasted females (supplemental Fig. S8, available at www.jneurosci.org
Sirt1-deficient mice exhibit defects in neurobehavioral
as supplemental material). After 14 d DR, the BRASTO DMH and
adaptation to diet-restricting conditions
LH exhibited 32% and 43% increases in the numbers of cFOSTo examine whether SIRT1 is necessary for neurobehavioral adpositive cells, respectively, compared to those in control mice
aptation to diet-restricting conditions, we decided to examine
(DMH, p ⫽ 0.008; LH, p ⫽ 0.049) (Fig. 3B; supplemental Fig. S7C,
Sirt1-deficient (Sirt1 ⫺/ ⫺) mice. Our Sirt1 ⫺/ ⫺ mice were backavailable at www.jneurosci.org as supplemental material), whereas
crossed to FVB. With this genetic background, Sirt1 ⫺/ ⫺ mice
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grow to adulthood with no significant
early mortality (A.S., C.S.B., and S.I., unpublished observation), despite their previously reported small body size (Cheng et
al., 2003; McBurney et al., 2003). We put
these Sirt1 ⫺/ ⫺ mice under a 14 d DR and
examined the effects of this dietary change
on their daily locomotor activity levels.
Consistent with previously reported findings (Chen et al., 2005), diet-restricted
Sirt1 ⫺/ ⫺ mice failed to show significant
increases in general ambulatory or rearing
activity over a 24 h light/dark cycle,
whereas diet-restricted Sirt1⫹/⫹ mice significantly increased these indices of activity compared to levels observed during ad
libitum-fed state (Sirt1⫹/⫹ vs Sirt1 ⫺/ ⫺,
total ambulations in DR, p ⫽ 0.03; rearings in DR, p ⫽ 0.037) (Fig. 4 A; supplemental Table S1, available at www.
jneurosci.org as supplemental material)
(Yu et al., 1985; Chen et al., 2005). Furthermore, Sirt1 ⫺/ ⫺ mice only showed
marginal increases in FAA compared to
controls in the timed DR paradigm
(ZT0 – 6, p ⬍ 0.001) (Fig. 4B).
We also compared levels of hypothalamic neural activation in Sirt1 ⫺/ ⫺ and
control mice under different diet-restricting
conditions. In contrast to BRASTO mice,
Sirt1 ⫺/ ⫺ mice showed significantly lower
numbers of cFOS-positive cells in both
the DMH and LH compared to controls in
response to 14 d DR (DMH, p ⫽ 0.006;
LH, p ⬍ 0.001) (Fig. 4C, left panel). With
this genetic background, we also detected
a small but significant difference in the
Arc between Sirt1⫹/⫹ and Sirt1 ⫺/ ⫺ mice. Figure 4. Sirt1-deficient mice have defects in neurobehavioral adaptation to diet-restricting conditions. A, Numbers of total
After 48 h fasting, the Sirt1 ⫺/ ⫺ DMH also ambulations (left) and rearings (right) of Sirt1 ⫹/⫹ and Sirt1 ⫺/ ⫺ mice under AL and 14 d DR conditions are shown as mean
showed significantly lower numbers of values ⫾ SEM (*p ⬍ 0.05 by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 5 mice). B, Wheel-running activity levels of
cFOS-positive cells compared to the Sirt1 ⫺/ ⫺ and Sirt1 ⫹/⫹ mice during a timed DR paradigm. Activity counts per hour of control mice (left) and Sirt1 ⫺/ ⫺ mice
Sirt1⫹/⫹ DMH, although the Sirt1 ⫺/ ⫺ LH (right) through a 24 h light/dark cycle are shown. Shading represents feeding time (ZT6 to 10). Counts at each time point are shown
did not show a decrease in this genetic as mean values ⫾ SEM (day 0 vs day 5, *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001 by paired Student’s t or Wilcoxon matched-pairs
⫹/⫹
⫺/ ⫺ †
, p ⬍ 0.001 by a Wilcoxon matched-pairs signed-ranks test, n ⫽ 9 and 4 for Sirt1⫹/⫹
background and condition (DMH, p ⫽ signed-ranks tests; Sirt1 vs Sirt1
⫺/ ⫺
and
Sirt1
mice,
respectively).
C,
Quantification
of the number of cFOS-positive cells in hypothalamic nuclei after 14 d DR (left),
0.011; LH, p ⫽ 0.611) (Fig. 4C, middle
⫺/ ⫺
48
h
fasting
(middle),
and
5
d
of
timed
DR
(right)
in
Sirt1
mice (*p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001, n ⫽ 3 mice for DR and
panel). In the timed DR paradigm, a sigfasting, 6 –9 sections per hypothalamic nucleus; n ⫽ 2 mice for timed DR, 2–7 sections per hypothalamic nucleus). The numbers
nificant decrease in the number of cFOSof cFOS-positive cells are shown as mean values ⫾ SEM. D, E, Rectal body temperature of Sirt1 ⫹/⫹ and Sirt1 ⫺/ ⫺ mice during
positive cells was again observed in the 14 d DR (D) and after 48 h fasting (E). Levels of rectal body temperature are shown as mean values ⫾ SEM (*p ⬍ 0.05, ***p ⬍
Sirt1 ⫺/ ⫺ DMH at ZT4 ( p ⫽ 0.033) (Fig. 0.001 by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 5–10 for 48 h fasting, n ⫽ 5 for DR).
4C, right panel). Consistent with lower
levels of neural activation in the Sirt1 ⫺/ ⫺
restricting conditions, we conducted microarray analyses to
DMH and LH, Sirt1 ⫺/ ⫺ mice were unable to maintain the range
⫹/⫹
compare gene expression profiles between whole hypothalami
of rectal body temperature detected in Sirt1
mice in response to
⫹/⫹
⫺/ ⫺
from 48 h fasted BRASTO and control mice. Although none of
these diet-restricting conditions (Sirt1
vs Sirt1
, DR, p ⫽
the gene expression changes reached statistical significance in this
0.049; fasted, p ⬍ 0.001) (Fig. 4D,E; supplemental Table S1, availparticular experiment (data not shown), we noted that several
able at www.jneurosci.org as supplemental material). Together,
genes previously reported to regulate neural signaling and activthese findings demonstrate that SIRT1 is necessary for the neurobeity might have important functional connections to the observed
havioral adaptation to acute and chronic diet-restricting paradigms.
phenotypes in BRASTO mice, including the genes encoding
orexin type 2 receptor (OX2R) (Sakurai et al., 1998), corticoSIRT1 upregulates genes that affect neural signaling and
tropin releasing hormone receptor 1 (CRHR1) (Müller and
activity in the DMH and LH
Wurst, 2004), and Ca 2⫹-activated K ⫹ channel (BK) ␤2 subunit
To address the molecular mechanism by which SIRT1 promotes
(KCNMB2) (Dai et al., 2009). We reexamined mRNA expression
neural activation in the DMH and LH in response to diet-
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as supplemental material). Given that
only specific hypothalamic nuclei exhibited significant neural activation in
BRASTO mice (Fig. 3A–C), we suspected
that local changes in gene expression
might be averaged out through the whole
hypothalamus. To analyze such local
changes in the expression of Ox2r and Kcnmb2, we conducted in situ hybridization
through multiple independent brain sections from 48 h-fasted BRASTO and
Sirt1 ⫺/ ⫺ mice. More Ox2r-positive cells
were clearly detected in the DMH and LH,
but not in other hypothalamic nuclei, of
BRASTO mice compared to those of wildtype controls (Fig. 5A). When assessing
total signal levels in the VMH, DMH, and
LH, Ox2r signal levels showed an ⬃80%
increase selectively in the BRASTO DMH
and LH relative to wild-type controls
(DMH, p ⫽ 0.02; LH, p ⫽ 0.028) (Fig. 5B).
qRT-PCR results with laser-microdissected samples of each hypothalamic
nucleus also confirmed that Ox2r expression levels increased specifically in the
BRASTO DMH and LH compared to
wild-type controls (DMH, p ⫽ 0.038; LH,
p ⫽ 0.049) (Fig. 5C,D), consistent with the
observed enhancement of neural activation in the BRASTO DMH and LH under
diet-restricting conditions (Fig. 3A–C). Kcnmb2 signal levels increased in 48 h-fasted
BRASTO hypothalami compared to control hypothalami, but this increase was
not limited to the DMH and LH (supplemental Fig. S10, available at www.
jneurosci.org as supplemental material).
Conversely, fasted Sirt1 ⫺/ ⫺ mice showed
fewer Ox2r-positive cells and decreases in
total Ox2r signal levels in the DMH, but
not in the LH, compared to fasted
⫹/⫹
mice (DMH, p ⫽ 0.038; LH, p ⫽
Figure 5. SIRT1 upregulates genes that affect neural signaling and activity in the DMH and LH. A, The in situ hybridization of Sirt1
Ox2r (green) in the DMH and LH in BRASTO mice fasted for 48 h. Nuclei were counterstained by DAPI (blue). Upper panel, Sense 0.769) (Fig. 5 E, F ), also consistent with
probe hybridization on wild-type sections; middle and lower panels, antisense probe hybridization on wild-type (WT) and BRASTO significant decreases in neural activation
(Tg) sections. B, Quantification of signal levels of Ox2r mRNA in the VMH, DMH and LH. Results are shown as mean values ⫾ SEM in the DMH of fasted Sirt1 ⫺/ ⫺ mice (Fig.
(*p ⬍ 0.05, n ⫽ 3– 4 mice for each genotype, 3– 8 sections per hypothalamic nucleus). C, D, Laser-microdissection of hypotha- 4C). Given that OX2R and orexin signallamic nuclei (C), and Ox2r expression levels in the Arc, VMH, DMH, and LH by real-time qRT-PCR (D). Results are shown as mean ing have been reported to play an imvalues ⫾ SEM (*p ⬍ 0.05, n ⫽ 4 mice for each genotype). E, F, The in situ hybridization of Ox2r (green) in the DMH and LH in
portant role in the regulation of sleep,
Sirt1⫹/⫹ and Sirt1 ⫺/ ⫺ mice fasted for 48 h (E), and signal levels of Ox2r mRNA in the VMH, DMH, and LH are shown as mean
physical activity, and metabolism
values ⫾ SEM (F ) (*p ⬍ 0.05, n ⫽ 2–3 mice for each genotype, 3– 6 sections per hypothalamic nucleus).
(Sakurai et al., 1998; Chemelli et al., 1999;
Funato et al., 2009), these results suggest
levels of those genes in 48 h fasted BRASTO, Sirt1 ⫺/ ⫺, and conthat the Ox2r gene might be a critical target of SIRT1 in the DMH
trol mice by qRT-PCR. Interestingly, all three genes showed opand LH in response to diet-restricting conditions.
posite directions of changes between BRASTO and Sirt1 ⫺/ ⫺ mice
(supplemental Fig. S9, available at www.jneurosci.org as suppleDiet restriction augments Ox2r expression in the DMH and
mental material). In particular, Ox2r and Kcnmb2 exhibited inLH through SIRT1
creases in BRASTO hypothalami and remarkable decreases in
To test whether Ox2r expression is indeed induced by SIRT1 in
Sirt1 ⫺/ ⫺ hypothalami, compared to respective controls. In conresponse to DR, we examined Ox2r expression profiles in hypotrast, the orexin type 1 receptor gene (Ox1r) (Sakurai et al., 1998) and
thalami of diet-restricted wild-type mice. Similar to the results in
the L-type voltage-gated Ca 2⫹ channel subtype Cav1.3 gene, whose
BRASTO hypothalami (Fig. 5 A, B), DR increased the number of
product is functionally coupled with BK channels (Berkefeld et al.,
Ox2r-positive cells and total Ox2r signal levels significantly and
2006), did not show any changes in fasted BRASTO and Sirt1 ⫺/ ⫺
specifically in the DMH and LH, but not in the VMH (DMH, p ⫽
hypothalami (supplemental Fig. S9, available at www.jneurosci.org
0.002; LH, p ⫽ 0.028; VMH, p ⫽ 0.718) (Fig. 6 A, B). This DR-
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induced enhancement of Ox2r expression
was totally abrogated in the Sirt1 ⫺/ ⫺
DMH and LH (DMH, p ⫽ 0.013; LH, p ⫽
0.015; VMH, p ⫽ 0.203) (Fig. 6C,D), suggesting that SIRT1 is required for DRinduced enhancement of Ox2r expression
in the DMH and LH. Furthermore, we
found that SIRT1 was able to enhance the
activity of the Ox2r promoter in a dosedependent manner in cultured cells (1 g,
p ⫽ 0.005; 2 g, p ⬍ 0.001) (Fig. 6 E). To
validate the relevance of this in vitro result,
we also conducted chromatin-immunoprecipitation (ChIP) assays with isolated
mouse hypothalami to examine whether
SIRT1 resides in the Ox2r promoter region in vivo. ChIP analyses revealed that
SIRT1 resided specifically in the Ox2r
proximal promoter region spanning from
⫺110 bp to ⫺457 bp (Fig. 6 F). Thus,
these findings suggest that increased
SIRT1 activity in BRASTO and dietrestricted hypothalami enhances Ox2r expression and promotes neural activation
specifically in the DMH and LH, which
tightly correlates with enhanced physical
activity in response to diet-restricting
conditions.
The gut hormone ghrelin induces
enhanced neural activation in
BRASTO hypothalami
Because DR apparently imposes a signal
that stimulates DMH and LH neurons in
both wild-type and BRASTO mice, we
suspected that some hormones produced
in peripheral tissues in response to DR
might generate such a stimulatory signal Figure 6. Diet restriction augments Ox2r expression in the DMH and LH via SIRT1. A–D, In situ hybridization of Ox2r in the DMH
⫺/ ⫺
FVB male mice (C, D) under 14 d DR. Ox2r signal levels were quantified
in the hypothalamus. We were particu- and LH in wild-type C57BL/6 male mice (A, B) and Sirt1
in
each
hypothalamic
nucleus
under
AL
and
14
d
DR
(B)
and between diet-restricted Sirt1⫹/⫹ and Sirt1 ⫺/ ⫺ mice (D). The signal
larly interested in ghrelin, an orexigenic
⫾ SEM
hormone secreted from stomach, because intensity per area was digitally quantified after subtracting surrounding background. Results are shown as mean values⫹/⫹
(*p ⬍ 0.05, **p ⬍ 0.01, n ⫽ 3– 4 each for AL and DR mice (4 –10 sections and per hypothalamic nucleus) and for Sirt1
and
ghrelin has been reported to stimulate Sirt1 ⫺/ ⫺ mice (2– 8 sections per hypothalamic nucleus)). E, Luciferase activities were measured by transfecting HEK293 cells with
orexin neurons in LH (Horvath et al., a luciferase reporter driven by a ⬃1 kb Ox2r promoter and a Sirt1 minigene or a control vector carrying only the Sirt1 promoter.
2001) and in culture (Yamanaka et al., Luciferase activities were compared with increasing amounts of the Sirt1 minigene. The luciferase activities in cells transfected with
2003). It has also been shown that periph- the promoter-only control vector are normalized to 100%. Results are shown as mean values ⫾ SEM (**p ⬍ 0.01, ***p ⬍ 0.001
eral injection of ghrelin increases the num- by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 4). F, Chromatin immunoprecipitation for SIRT1 in the hypothalamus.
ber of cFOS-positive cells in the DMH in Fixed chromatin was sonicated and subjected to immunoprecipitation with an anti-SIRT1 polyclonal antibody. Extracted DNA was
rats (Kobelt et al., 2008). Therefore, we hy- amplified with each primer set. Primer set 1 was designed for an unrelated genomic region. Locations of primer sets 2– 4 are shown
pothesized that ghrelin contributes to the in the upper panel. Rabbit IgG (rIgG) was used as a negative control.
peripheral signal responsible for stimulating
tween wild-type and BRASTO mice, ghrelin induced cFOS-positive
DMH and LH neurons in response to DR in wild-type and BRASTO
cells in the Arc, DMH, and LH over 2 h after injection, and the
mice. We first examined serum ghrelin levels in AL and dietBRASTO DMH and LH showed significantly higher numbers of
restricted mice. Ghrelin levels significantly increased in mice under
cFOS-positive cells than control DMH and LH after ghrelin inDR, compared to those in AL mice ( p ⫽ 0.006) (Fig. 7A, left). Ghjection (WT vs Tg, DMH, p ⫽ 0.017; LH, p ⫽ 0.019) (Fig. 7B).
relin levels also increased similarly in both 48 h fasted control and
Consistent with this DMH- and LH-specific enhancement of
BRASTO mice (WT, p ⬍ 0.001; Tg, p ⬍ 0.001) (Fig. 7A, right; supneural activation in BRASTO mice, they were also able to mainplemental Table S1, available at www.jneurosci.org as supplemental
tain higher levels of rectal body temperature compared to conmaterial). We next compared neural activation in control and
trols after ghrelin injection (WT vs Tg, p ⫽ 0.048) (Fig. 7C;
BRASTO hypothalami to peripheral ghrelin injection. After 4 d of
supplemental Table S1, available at www.jneurosci.org as supplehabituation to handling and mock injection to avoid stress-induced
mental material), which mimics the changes in rectal body temneural activation, we injected PBS or ghrelin intraperitoneally into
perature observed in diet-restricted wild-type and BRASTO mice
both control and BRASTO mice. Whereas control PBS injection
(Fig. 3E). Interestingly, the majority of cFOS-positive cells were
showed minimal cFOS induction with no baseline differences be-
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response to ghrelin through OX2R is significantly reduced in the Sirt1 ⫺/ ⫺ LH and
DMH. Together, our findings indicate that
peripheral ghrelin, whose levels are significantly increased by diet-restricting conditions, triggers the stimulatory signal in the
DMH and LH where SIRT1 enhances the
responsiveness of neurons through the augmentation of Ox2r expression.

Discussion
SIRT1 functions as a key mediator for
the central adaptation to
diet restriction
In this study, we provide several lines of
evidence demonstrating the physiological
significance of SIRT1 in the regulation of
neurobehavioral adaptation to DR: (1)
SIRT1 protein levels and neural activation
are induced specifically in the DMH and
LH by DR, (2) increased SIRT1 dosage in
the brain significantly enhances neural activation in the DMH and LH, maintains a
higher range of body temperature, and
promotes physical activity in BRASTO
mice in response to multiple diet-restricting
paradigms, (3) these responses induced by
diet-restricting conditions are abrogated
by SIRT1 deficiency, (4) SIRT1 is required
for the DR-induced enhancement of Ox2r
expression in the DMH and LH and is also
able to enhance the promoter activity of
the Ox2r gene, and (5) ghrelin, a gut hormone whose plasma levels are signifiFigure 7. Ghrelin stimulates OX2R-positive neurons in the BRASTO DMH and LH, but not in Sirt1-deficient mice. A, Serum levels cantly increased by both 48 h fasting and
of ghrelin in AL and DR wild-type mice (left) and in fed and fasted BRASTO (Tg) and control (WT) mice (right). Ghrelin levels are DR, stimulates OX2R-positive neurons in
shown as mean values ⫾ SEM (**p ⬍ 0.01, ***p ⬍ 0.001 by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 5 for each the DMH and LH and maintains higher
condition). B, The number of cFOS-positive cells in the Arc, DMH, and LH of wild-type (WT) and BRASTO (Tg) mice at 90 min (left) body temperature in BRASTO mice, while
and 120 min (right) after ghrelin injection (30 nmol/kg of body weight) and after PBS injection (right). cFOS-positive cells are Sirt1 ⫺/ ⫺ mice show significantly reduced
shown as mean values ⫾ SEM (*p ⬍ 0.05, **p ⬍ 0.01 by one-way ANOVA with Tukey–Kramer post hoc test for each hypothalamic
neural activation through OX2R in the
nucleus, ghrelin injection, 90 min, n ⫽ 2–3 mice for each genotype, 7–12 sections per hypothalamic nucleus; 120 min, n ⫽ 3 for
DMH and LH. These findings suggest that
each genotype, 3–7 sections per hypothalamic nucleus, PBS injection, n ⫽ 2 for each genotype, 6 –7 sections per hypothalamic
nucleus). C, Rectal body temperature of BRASTO mice 120 min after ghrelin injection. Levels of rectal body temperature are shown SIRT1 controls a central adaptive mechaas mean values ⫾ SEM (*p ⬍ 0.05, **p ⬍ 0.01 by one-way ANOVA with Tukey–Kramer post hoc test, n ⫽ 6 –7). D, Double nism by which animals maintain their
immunofluorescent staining of cFOS and OX2R in the DMH and LH of wild-type (WT) and BRASTO (Tg) mice at 120 min after ghrelin physical activity and body temperature in
injection. Arrows indicate cFOS/OX2R-double-positive cells. E, Quantification of the number of cFOS/OX2R-double-positive cells in response to relatively chronic energy limthe Arc, DMH and LH of wild-type (WT) and BRASTO (Tg) mice at 120 min after ghrelin injection. cFOS/OX2R-double-positive cells itation. Given that BRASTO mice show an
are shown as mean values ⫾ SEM (*p ⬍ 0.05, n ⫽ 3 mice for each genotype, 3–7 sections per hypothalamic nucleus). F, enhancement of these neurobehavioral
Percentage of cFOS/OX2R-double-positive cells compared to a total number of cFOS-positive cells in the Arc, DMH, and LH of responses to DR, whereas Sirt1 ⫺/ ⫺ mice
Sirt1⫹/⫹ and Sirt1 ⫺/ ⫺ mice at 120 min after ghrelin injection. Percentages of cFOS/OX2R-double-positive cells are shown as exhibit defects in these responses, persismean values ⫾ SEM (*p ⬍ 0.05, ***p ⬍ 0.001, n ⫽ 3 mice for each genotype, 6 –12 sections per hypothalamic nucleus). G, A
tent low energy intake such as DR likely
model for the SIRT1-mediated neurobehavioral adaptation in the hypothalamus in response to DR. See Discussion for details.
triggers this adaptive mechanism by augmenting SIRT1 activity and thereby Ox2r
expression, at least in part, in the DMH
also OX2R-positive (82 and 72% in the Arc, 77 and 79% in the
and
LH
and
enhancing
the sensitivity of OX2R-positive neurons
DMH, and 57 and 72% in the LH in control and BRASTO mice,
to signals imposed possibly by peripheral ghrelin.
respectively, at 120 min after ghrelin injection) (Fig. 7D), and the
numbers of cFOS/OX2R-double-positive cells were significantly
A novel central connection between SIRT1 and OX2Rhigher in the BRASTO DMH and LH compared to controls at 120
mediated orexin signaling
min after ghrelin injection (DMH, p ⫽ 0.015; LH, p ⫽ 0.012)
Our finding that SIRT1 enhances Ox2r expression specifically in
(Fig. 7E). We also examined the response of Sirt1⫹/⫹ and
Sirt1 ⫺/ ⫺ mice to peripheral ghrelin injection. Among all actithe DMH and LH in response to DR illustrates a novel central
vated neurons, the percentages of cFOS/OX2R-double-positive
connection between two key players in the regulation of metabcells were significantly lower in the Sirt1 ⫺/ ⫺ DMH and LH
olism and behavior. Orexin-OX1/2R signaling has been demon(DMH, p ⬍ 0.001; LH, p ⫽ 0.042) (Fig. 7F ), suggesting that the
strated to play a critical role in the central regulation of arousal,
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motivational components of physical activity, and metabolism
(Sakurai et al., 1998; Chemelli et al., 1999; Funato et al., 2009). In
particular, hypothalamic orexin signaling plays an essential role
in the fasting-induced enhancement of wakefulness and locomotor activity (Yamanaka et al., 2003). It has also been shown that
orexin neuron-ablated mice have a severe defect in the foodanticipatory enhancement of wakefulness and locomotor activity
under timed DR (Mieda et al., 2004). It has recently been demonstrated that orexin-OX2R signaling regulates metabolic rate,
food intake, and leptin and insulin sensitivity and thereby conveys resistance to high-fat diet-induced metabolic complications
(Funato et al., 2009). Thus, hypothalamic orexin signaling functions as a critical mediator of central adaptive responses to alterations in energy intake.
Similarly, it has been well established that SIRT1 mediates a
variety of critical metabolic effects in response to nutritional cues,
particularly to low nutritional input, in major metabolic tissues,
such as liver, adipose tissue, and skeletal muscle (Sinclair, 2005;
Imai and Guarente, 2007; Schwer and Verdin, 2008; Imai and
Guarente, 2010). Most recently, it has been reported that pharmacological inhibition or Arc-specific knockdown of hypothalamic SIRT1 suppresses food intake and body weight gain, likely
through the central melanocortin signaling, in rats (Cakir et al.,
2009). SIRT1 is expressed in pro-opiomelanocortin (POMC)
neurons (Ramadori et al., 2008) and appears to regulate Pomc
expression through deacetylation of FOXO1 (Cakir et al., 2009).
These studies reveal hypothalamic SIRT1 function in response to
acute nutritional deprivation. Our present study further extends
this interesting aspect of SIRT1 function in the hypothalamus
and reveals a new metabolic role of SIRT1 in different hypothalamic nuclei, namely the DMH and LH, in response to more
chronic nutritional alterations. SIRT1 appears to control the sensitivity of a particular subset of neurons in the DMH and LH
through the regulation of Ox2r expression and makes them more
responsive to increased ghrelin signal under DR (Fig. 7G). Because ghrelin directly stimulates orexin neurons (Horvath et al.,
2001; Yamanaka et al., 2003), it is highly likely that those OX2Rpositive DMH and LH neurons are stimulated by the orexin neurons that are activated by ghrelin (Fig. 7G). Although further
investigation will be necessary to clarify the entire signaling cascade, the augmentation of OX2R-mediated neural activation in
response to DR appears to be accomplished by the localized increase in SIRT1 protein levels in the DMH and LH. Nonetheless,
because BRASTO mice do not show significant phenotypes in AL
conditions, hypothalamic SIRT1 activity might also be augmented by increased systemic NAD biosynthesis or other mechanisms activated by low nutritional input, as reported in other
cases (Cakir et al., 2009; Imai, 2009b). Detailed analyses are currently underway to elucidate the molecular mechanism by which
SIRT1 augments Ox2r expression specifically in the DMH and
LH in response to low nutritional input.
The SIRT1-mediated systemic regulatory network for
adaptive responses to diet restriction
It should be noted that persistent neural activation is observed in
the DMH and LH under DR, although other hypothalamic nuclei, such as the Arc and VMH, might be involved in regulatory
processes that trigger metabolic changes at an early stage during
DR. Our findings suggest that SIRT1 in the OX2R-positive DMH
and LH neurons might play a critical role in coordinating metabolic responses to chronic diet-restricting conditions at a systemic level. Although their precise nature is currently unclear, the
activation of these OX2R-positive DMH and LH neurons leads to

the stimulation of thermogenesis and the elevation of physical
activity in response to relatively chronic diet-restricting conditions. Increasing SIRT1 dosage further promotes these responses,
whereas SIRT1 deficiency abrogates them. Given that it has been
shown that DMH and LH neurons regulate thermogenesis in
brown adipose tissue through the control of sympathetic nerve
activity (Cerri and Morrison, 2005; DiMicco and Zaretsky, 2007;
Morrison et al., 2008), it is tempting to speculate that SIRT1
activity in these neurons might affect such systemic responses
through the regulation of sympathetic nerve activity. However, in
light of the complexity of hypothalamic circuits, the fact that
some hypothalamic nuclei appear to be more homogeneous than
others in their responses does not necessarily allow us to conclude
that those particular nuclei are central in such systemic responses.
Definitive tests await the generation of necessary genetic tools,
such as DMH- or LH-specific Cre-driver mice. Nonetheless, it
will also be of great importance to examine where these OX2Rpositive DMH and LH neurons send their projections and which
neurons control activities of those DMH and LH neurons.
It is conceivable that those specific hypothalamic neurons, as
well as other hypothalamic neurons such as AgRP and POMC
neurons, might also be important for age-associated alterations
in neurobehavioral adaptive responses to nutritional inputs and
possibly for longevity as well in mammals, given that it has been
demonstrated that a very specific subset of sensory neurons,
namely SKN-1-positive neurons, mediates DR-induced longevity through an endocrine mechanism in C. elegans (Bishop and
Guarente, 2007b). Such a hierarchical regulatory network might
play a universal role in the regulation of aging and longevity in
animals, and SIRT1 might be an integral component in the DMH
and LH to modulate systemic signals in response to changes in
energy intake in mammals. Indeed, peripheral administration of
ghrelin, an orexigenic hormone produced in the stomach, triggers the activation of the DMH and LH neurons and induces
changes in body temperature, mimicking the effect of DR. Increased SIRT1 dosage enhances this neural response to ghrelin
and allows animals to maintain a higher range of body temperature. Therefore, SIRT1 might function as a critical modulator in
this hierarchical regulatory network for the regulation of central
adaptive responses. Alteration in SIRT1 activity in these neurons
might cause significant changes in the system dynamics of this
adaptive mechanism. In this regard, it is intriguing that systemic
NAD biosynthesis appears to decline over age, resulting in reductions in SIRT1 activity and glucose-stimulated insulin secretion
in pancreatic ␤ cells in aged mice (Ramsey et al., 2008; Imai,
2009b). Such an age-associated decrease in systemic NAD biosynthesis might contribute to the alteration of certain neurobehavioral adaptations, such as reduced motivation for activity and
sleep disorders, both of which are common in the elderly (Kmiec,
2006).
In conclusion, our present study demonstrates the physiological significance of SIRT1 as a key central mediator for the
neurobehavioral adaptation to DR. These findings provide
critical insights into the molecular mechanism by which mammals control their neurobehavioral adaptive responses to
search for food and to survive through diet-restricted, lifethreatening environments.
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